Skip Nav Destination
Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
Clin Cancer Res (2015) 21 (9): 2192.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Xiancui Zhu
- Mengchen Xu
- Jinrong Sun
- Dianjun Guo
- Yiwei Zhang
- Shuangliu Zhou
- Shaowu Wang
European Journal of Organic Chemistry (2021) 2021 (37): 5213.
- X Jiang
- Y Bao
- H Liu
- X Kou
- Z Zhang
- F Sun
- Z Qian
- Z Lin
- X Li
- X Liu
- L Jiang
- Y Yang
Oncogene (2017) 36 (50): 6850.
